Phone: þ46 (0) 18 471 3382, Fax: þ46 (0) 18 555 095Cu 2 ZnSn(S,Se) 4 (CZTS(e)) solar cells suffer from low-opencircuit voltages that have been blamed on the existence of band gap fluctuations, with different possible origins. In this paper, we show from both theoretical and experimental standpoints that disorder of Cu and Zn atoms is in all probability the primary cause of these fluctuations. First, quantification of Cu-Zn disorder in CZTS thin films is presented. The results indicate that disorder is prevalent in the majority of practical samples used for solar cells. Then, ab initio calculations for different arrangements and densities of disorder-induced [Cu Zn þ Zn Cu ] defect pairs are presented and it is shown that spatial variations in band gap of the order of 200 meV can easily be caused by Cu-Zn disorder, which would cause large voltage losses in solar cells. Experiments using Raman spectroscopy and room temperature photoluminescence combined with in situ heat-treatments show that a shift in the energy of the dominant band-to-band recombination pathway correlates perfectly to the order-disorder transition, which clearly implicates Cu-Zn disorder as the cause of band gap fluctuations in CZTS. Our results suggest that elimination or passivation of Cu-Zn disorder could be very important for future improvements in the efficiency of CZTS(e)-based solar cells.
A precursor‐annealing process based on a Cu‐rich precursor that has a maximum power conversion efficiency of 7.5% for pure selenide kesterite cells is presented. The Cu‐rich step is beneficial for the transport properties. Nanometer‐sized domains of ZnSe are found in all films.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.